Cargando…
A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study
BACKGROUND: Breast cancer (BC) is the most frequent cancer in women. The tumor microenvironment (TME), consisting of blood vessels, immune cells, fibroblasts, and extracellular matrix, plays a pivotal role in tumorigenesis and progression. Increasing evidence has emphasized the importance of TME, es...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636929/ https://www.ncbi.nlm.nih.gov/pubmed/34867821 http://dx.doi.org/10.3389/fendo.2021.774244 |
_version_ | 1784608636501229568 |
---|---|
author | Huang, Yizhou Chen, Lizhi Tang, Ziyi Min, Yu Yu, Wanli Yang, Gangyi Zhang, Lili |
author_facet | Huang, Yizhou Chen, Lizhi Tang, Ziyi Min, Yu Yu, Wanli Yang, Gangyi Zhang, Lili |
author_sort | Huang, Yizhou |
collection | PubMed |
description | BACKGROUND: Breast cancer (BC) is the most frequent cancer in women. The tumor microenvironment (TME), consisting of blood vessels, immune cells, fibroblasts, and extracellular matrix, plays a pivotal role in tumorigenesis and progression. Increasing evidence has emphasized the importance of TME, especially the immune components, in patients with BC. Nevertheless, we still lack a deep understanding of the correlation between tumor invasion and TME status. METHODS: Transcriptome and clinical data were retrieved from The Cancer Genome Atlas (TCGA) database. ESTIMATE algorithm was applied for quantifying stromal and immune scores. Then we screened out the differentially expressed genes (DEGs) through the intersection analysis. Furthermore, the establishment of protein-protein interaction (PPI) network and univariate COX regression analysis were utilized to determine the core genes in DEGs. In addition, we also performed Gene Set Enrichment Analysis (GSEA) and CIBERSORT analysis to distinguish the function of crucial gene expression and the proportion of tumor-infiltrating immune cells (TICs), respectively. RESULTS: A total of 1178 samples (112 normal samples and 1066 tumor samples) were extracted from TCGA for calculation, and 226 DEGs were obtained from this assessment. Further intersection analysis revealed eight key genes, including ITK, CD3E, CCL19, CD2, SH2D1A, CD5, SLAMF6, SPN, which were proven to correlate with BC status. Moreover, ITK was picked out for further study. The results illustrated that high expression of BC patients had a more prolonged overall survival (OS) time than ITK low expression BC patients (p = 0.009), and ITK expression also presented the statistical significance in age, TNM staging, tumor size classification, and metastasis classification. Additionally, GSEA and CIBERSORT analysis indicated that ITK expression had an association with immune activity in TME. CONCLUSION: ITK may be a potential indicator for prognosis prediction in patients with BC, and its biological behavior may promote our understanding of the molecular mechanism of tumor progression and targeted therapy. |
format | Online Article Text |
id | pubmed-8636929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86369292021-12-03 A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study Huang, Yizhou Chen, Lizhi Tang, Ziyi Min, Yu Yu, Wanli Yang, Gangyi Zhang, Lili Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Breast cancer (BC) is the most frequent cancer in women. The tumor microenvironment (TME), consisting of blood vessels, immune cells, fibroblasts, and extracellular matrix, plays a pivotal role in tumorigenesis and progression. Increasing evidence has emphasized the importance of TME, especially the immune components, in patients with BC. Nevertheless, we still lack a deep understanding of the correlation between tumor invasion and TME status. METHODS: Transcriptome and clinical data were retrieved from The Cancer Genome Atlas (TCGA) database. ESTIMATE algorithm was applied for quantifying stromal and immune scores. Then we screened out the differentially expressed genes (DEGs) through the intersection analysis. Furthermore, the establishment of protein-protein interaction (PPI) network and univariate COX regression analysis were utilized to determine the core genes in DEGs. In addition, we also performed Gene Set Enrichment Analysis (GSEA) and CIBERSORT analysis to distinguish the function of crucial gene expression and the proportion of tumor-infiltrating immune cells (TICs), respectively. RESULTS: A total of 1178 samples (112 normal samples and 1066 tumor samples) were extracted from TCGA for calculation, and 226 DEGs were obtained from this assessment. Further intersection analysis revealed eight key genes, including ITK, CD3E, CCL19, CD2, SH2D1A, CD5, SLAMF6, SPN, which were proven to correlate with BC status. Moreover, ITK was picked out for further study. The results illustrated that high expression of BC patients had a more prolonged overall survival (OS) time than ITK low expression BC patients (p = 0.009), and ITK expression also presented the statistical significance in age, TNM staging, tumor size classification, and metastasis classification. Additionally, GSEA and CIBERSORT analysis indicated that ITK expression had an association with immune activity in TME. CONCLUSION: ITK may be a potential indicator for prognosis prediction in patients with BC, and its biological behavior may promote our understanding of the molecular mechanism of tumor progression and targeted therapy. Frontiers Media S.A. 2021-11-18 /pmc/articles/PMC8636929/ /pubmed/34867821 http://dx.doi.org/10.3389/fendo.2021.774244 Text en Copyright © 2021 Huang, Chen, Tang, Min, Yu, Yang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Huang, Yizhou Chen, Lizhi Tang, Ziyi Min, Yu Yu, Wanli Yang, Gangyi Zhang, Lili A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study |
title | A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study |
title_full | A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study |
title_fullStr | A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study |
title_full_unstemmed | A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study |
title_short | A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study |
title_sort | novel immune and stroma related prognostic marker for invasive breast cancer in tumor microenvironment: a tcga based study |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636929/ https://www.ncbi.nlm.nih.gov/pubmed/34867821 http://dx.doi.org/10.3389/fendo.2021.774244 |
work_keys_str_mv | AT huangyizhou anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT chenlizhi anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT tangziyi anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT minyu anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT yuwanli anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT yanggangyi anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT zhanglili anovelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT huangyizhou novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT chenlizhi novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT tangziyi novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT minyu novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT yuwanli novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT yanggangyi novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy AT zhanglili novelimmuneandstromarelatedprognosticmarkerforinvasivebreastcancerintumormicroenvironmentatcgabasedstudy |